High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
Wolfgang Warsch(Medical University of Vienna), Veronika Sexl(University of Vienna)
Cited by 187
Related Papers
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
|Nature Communications|2019|73
Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors
|Cancer Research|2004|66
Loss of JAK1 Drives Innate Immune Deficiency
|Frontiers in Immunology|2019|54